Hychlorzide 25 Tablet contains Hydrochlorothiazide 25 mg, a thiazide diuretic primarily indicated for the management of hypertension and edema associated with congestive heart failure, renal dysfunction, or hepatic cirrhosis. Hydrochlorothiazide acts by inhibiting sodium reabsorption in the distal convoluted tubules of the nephron, promoting increased excretion of sodium and water, thereby reducing plasma volume and peripheral vascular resistance. This mechanism contributes to its antihypertensive and diuretic effects. Hychlorzide 25 is commonly prescribed to lower elevated blood pressure, reducing the risk of cardiovascular events such as stroke and myocardial infarction. Additionally, it aids in the mobilization of excess fluid in conditions characterized by fluid retention. The onset of diuretic action typically occurs within 2 hours, with peak effects observed around 4 hours post-administration. Dosage should be individualized based on patient response and clinical condition, with regular monitoring of electrolytes, renal function, and blood pressure recommended to minimize potential adverse effects such as hypokalemia, hyponatremia, hyperuricemia, and dehydration. Caution is advised in patients with diabetes mellitus, gout, or impaired renal or hepatic function. Hychlorzide 25 should be used under medical supervision to ensure safe and effective therapy.